Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria S Asdourian

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Dermatology Reports|July 25, 2022
Neutrophilic Dermatosis and Management Strategies for the Inpatient DermatologistNishi Shah, Maria S Asdourian, Ted V Jacoby, et al.
Journal of the American Academy of Dermatology|October 13, 2022
Dercum's disease: A retrospective cohort studyMaria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
JAMA Dermatology|May 25, 2022
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer: A Systematic ReviewMaria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
The Lancet. Oncology|September 7, 2016
Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitisMaria S Asdourian, Melissa N Skolny, Cheryl Brunelle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to J. NudelmanMaria S Asdourian, Melissa N Skolny, Cheryl Brunelle, et al.
Physical Therapy|January 24, 2018
Hand Edema in Patients at Risk of Breast Cancer-Related Lymphedema: Health Professionals Should Take NoticeCheryl L Brunelle, Meyha N Swaroop, Melissa N Skolny, et al.
Current Breast Cancer Reports|September 13, 2017
Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future DirectionsHoda E Sayegh, Maria S Asdourian, Meyha N Swaroop, et al.
Clinical and Experimental Dermatology|May 12, 2023
Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuationTed V Jacoby, Maria S Asdourian, Nishi Shah, et al.
Journal of Surgical Oncology|November 5, 2016
In response to: Letter to the Editor by Kilbreath et alMeyha N Swaroop, Cheryl L Brunelle, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology|May 16, 2022
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapyMaria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Dermatology Reports|July 25, 2022
Neutrophilic Dermatosis and Management Strategies for the Inpatient DermatologistNishi Shah, Maria S Asdourian, Ted V Jacoby, et al.
Journal of the American Academy of Dermatology|October 13, 2022
Dercum's disease: A retrospective cohort studyMaria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
JAMA Dermatology|May 25, 2022
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer: A Systematic ReviewMaria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
The Lancet. Oncology|September 7, 2016
Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitisMaria S Asdourian, Melissa N Skolny, Cheryl Brunelle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to J. NudelmanMaria S Asdourian, Melissa N Skolny, Cheryl Brunelle, et al.
Physical Therapy|January 24, 2018
Hand Edema in Patients at Risk of Breast Cancer-Related Lymphedema: Health Professionals Should Take NoticeCheryl L Brunelle, Meyha N Swaroop, Melissa N Skolny, et al.
Current Breast Cancer Reports|September 13, 2017
Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future DirectionsHoda E Sayegh, Maria S Asdourian, Meyha N Swaroop, et al.
Clinical and Experimental Dermatology|May 12, 2023
Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuationTed V Jacoby, Maria S Asdourian, Nishi Shah, et al.
Journal of Surgical Oncology|November 5, 2016
In response to: Letter to the Editor by Kilbreath et alMeyha N Swaroop, Cheryl L Brunelle, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology|May 16, 2022
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapyMaria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
Pageof 3